Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maintenance Regimen for Advanced Breast Cancer Survivors
NCT03423849Phase 3Unknown
- Start
- Feb 2018
- Primary completion
- Feb 2020
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
01
Overview
A Phase 3 trial of vinorelbine, capecitabine, gemcitabine, cisplatin in breast cancer. Status: unknown.
02
Drugs
vinorelbinecapecitabinegemcitabinecisplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03423849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03423849.